Viral Hepatitis Across the Spectrum From Preconception and to Adulthood: Closing Gaps in Hepatitis B and Hepatitis C Prevention and Care, Part 2

Nov 07 2026
Convention Center: Mile High Ballroom 2B-3B
2:00 PM - 3:30 PM
Captured/recorded session Recorded
CE Credits CE Credits

Description

Jointly presented by the Hepatitis C and Hepatitis B/Delta Special Interest Groups, the Women's Initiative Committee, and the LGBTQ Subcommittee, this timely and unique 2-part program focuses on updates and approaches to hepatitis B and hepatitis C prevention and care across the lifespan—from preconception to adulthood. Speakers cover important considerations for women of childbearing age living with hepatitis B and/or hepatitis C preconception, including assisted reproduction considerations and updates in approaches to care for hepatitis B and hepatitis C in pregnant individuals. Other core topics include: updates in hepatitis B neonatal vaccination; pediatric treatment of hepatitis B and hepatitis C; and considerations for prevention management among LGBTQ individuals living with hepatitis B and/or hepatitis C. Discussions include a patient advocate panelist, representing the patient voice.

Presentations

2:25 PM - 2:50 PM
Convention Center - Mile High Ballroom 2B-3B
Recorded session

Viral Hepatitis Care in LGBTQ+ Individuals

Howard (Tzu-Hao) Lee, MD | Presenter
2:50 PM - 3:15 PM
Convention Center - Mile High Ballroom 2B-3B
Recorded session

Hepatitis B Care From Neonates to Adolescents

Kathleen B. Schwarz, MD, FAASLD | Presenter
2:00 PM - 2:25 PM
Convention Center - Mile High Ballroom 2B-3B
Recorded session

Approaches to Hepatitis C Care in Childhood to Adolescence

James E Squires, MD, MS | Presenter

Objectives

  • Review incorporation of system-level strategies to enhance hepatitis B screening, vaccination, linkage, and long-term retention in clinical settings across the reproductive lifespan.
  • Identify key care gaps and interventions to decrease hepatitis B and hepatitis C transmission in preconception, pregnancy, and postpartum settings.
  • Relate strategies to apply population-specific microelimination and hepatitis B treatment approaches, including neonatal/pediatric, pregnancy-based, sexual healthintegrated, and harmareduction models, to improve hepatitis B outcomes.